Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ALLO | Allogene Therapeutics, Inc. | EVP of R&D | $5.85M | -$80.4K | -1.36% | Feb 3, 2025 |
TIL | Instil Bio, Inc. | Chief Medical Officer | Mar 4, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|